Sinopharm
1099.HK
#2581
Rank
NZ$12.21 B
Marketcap
NZ$3.91
Share price
-0.06%
Change (1 day)
-14.62%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2022: NZ$0.71

According to Sinopharm's latest financial reports the company's current EPS (TTM) is NZ$0.59. In 2022 the company made an earnings per share (EPS) of NZ$0.71 an increase over its 2021 EPS that were of NZ$0.70.

EPS history for Sinopharm from 2006 to 2022

Annual EPS

Year EPS Change
2022NZ$0.711.3%
2021NZ$0.7010.33%
2020NZ$0.6317.26%
2019NZ$0.545.44%
2018NZ$0.51-0.87%
2017NZ$0.5219.44%
2016NZ$0.4315.3%
2015NZ$0.3817.06%
2014NZ$0.3221.9%
2013NZ$0.2611.82%
2012NZ$0.2425.24%
2011NZ$0.1931.02%
2010NZ$0.143.3%
2009NZ$0.1446.85%
2008NZ$0.0946367.57%
2007NZ$0.05647310.24%
2006NZ$0.01377